We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Accern Stock

Invest in or calculate the value of your shares in Accern or other pre-IPO companies through EquityZen's platform.

Get Started

Accern Stock (ACC)

Accern is a no-code generative natural language processing platform that transforms content into solutions to solve enterprise problems.

About Accern Stock

Founded

2014

Headquarters

New York, NY, US

Industries

Software, Artificial Intelligence, Data and Analytics

Accern is a No-Code NLP Platform that empowers domain experts and business analysts to extract the most accurate insights from massive streams of unstructured data–including news, social media, industry reports, and internal documents—within minutes. Accern offers pre-built AI/ML/NLP solutions to minimize time to value and maximize ROI for equity research, credit risk, M&A activity, ESG performance, insurance claims, fraud prevention, sanctions monitoring, and more. Recognized as the first No-Code NLP platform and industry leader with the highest accuracy scores, Accern also enables data scientists to customize end-to-end AI/ML/NLP workflows with BYO datasets, taxonomies, models, and pre-integrated dashboards and DSML platforms. In production at companies like Allianz, William Blair, and Mizuho Bank, Accern accelerates innovation by enhancing existing models and enriching BI dashboards. Headquartered in New York City, Accern is backed by Fusion Fund, Mighty Capital, Shasta Ventures, and Tribe Capital.

Accern Management

Leadership team at Accern

Co-Founder & CEO

Kumesh Aroomoogan

Co-Founder & CTO

Dr. Anshul Pandey

Locked Features

Join now and verify your accreditation status to gain access to:

  • Accern current valuation
  • Accern stock price
  • Available deals in Accern and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Accern Stock

How to invest in Accern stock?

Accredited investors can buy pre-IPO stock in companies like Accern through EquityZen funds. These investments are made available by existing Accern shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Accern stock?

Shareholders can sell their Accern stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."